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Abstract.  
A versatile synthetic route to new 4-quinolone-based polycyclic systems is described. TFA-
catalyzed intramolecular reaction of N-unsubstituted quinolone-2-carboxylic acid amides gives 
structurally diverse compounds, depending on the length of the chain. Acid treatment of β-
oxoamides furnishes 3H-pyrazino[1,2-a]quinoline-4,6-diones, due to the nucleophilic attack of N-1 
to the carbonyl group, whereas TFA treatment of δ- and ε-oxoamides leads to the formation of 
tetracyclic compounds by a tandem heteroannulation reaction. 
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1. Introduction 
 
The quinolone moiety is an important structural unit in medicinal chemistry and many compounds 
with this scaffold have shown a broad range of biological properties including anticancer,1 
antimicrobial,2 antiviral3 and antimalarial4 activity.  
 3
In pursuance of our research on the development of new antitumor compounds, we became 
interested in accessing structurally diverse heterocyclic rings containing the quinolone moiety. 
In recent papers5 we reported that the TFA-catalyzed intramolecular Friedel-Crafts cyclization of 
indole-2-carboxylic acid β- or γ-oxoamides (1) represented a simple synthesis of β-carbolin-1-ones 
(2, m = 0) or dihydro-2H-azepino[3,4-b]indol-1-ones (2, m = 1) (Scheme 1). Conversely, acid 
treatment of δ-, ε-, and ζ-oxoamides preferentially gave intermediate N-acyliminium ions, which 
cyclized into the novel heterocyclic rings pyrrolizino[2,1-b]indole (4, m = 1), indolizino[2,1-
b]indole (4, m = 2), and 9a,11-diaza-indeno[1,2-a]azulene (4, m = 3).6  
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Scheme 1. TFA-catalyzed intramolecular Friedel-Crafts cyclization of indole-2-carboxylic acid oxoamides. 
 
As the method could provide a route to novel heterocyclic systems, we thought to extend the study 
to the preparation of quinolone-fused rings. 
Although numerous efforts have been made to modify quinolones, there are currently few reports 
concerning electrophilic substitutions at C-3 of 4-quinolone rings, even though 4-quinolone is 
known to be in tautomeric equilibrium with its phenol form.7 A survey of literature revealed few 
examples of Friedel-Crafts alkylation8 and acylation of 4-quinolones.9 Chlorination,10 bromination11 
and iodination12 reactions of 4-oxo-1,4-dihydro-quinoline-2-carboxylic acid derivatives are reported 
as well.  
These findings motivated us to apply the synthetic sequence to 4-quinolone-2-carboxamides. We 
herein describe the outcome of these reactions. 
 
2. Results and discussion 
 
The investigation began with N-methyl kynurenic acid 5a,13 which was obtained by treatment of N-
methylaniline with DMAD, followed by cyclization with PPA and basic hydrolysis.14 
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The coupling of 5a with 2-aminoethanol, through WSC and HOBt, gave the alcohol 6a. Oxidation 
of 6a, followed by treatment with TFA afforded the expected tricyclic compound 8, although in 
poor yield (21% overall) (Scheme 2). The yield was increased by coupling 5a with commercially 
available aminoacetaldehyde diethylacetal to obtain the amide 7a in 88% yield. Treatment of 7a 
with TFA gave the cyclization product in 75% yield. When the sequence was performed on the 
free-NH quinolone 5b, the reaction proceeded smoothly to give compound 9, derived from the 
attack of N-1 to the carbonyl group of the intermediate aldehyde, followed by elimination. 
Compound 9 was also obtained from the intermediate acetal 7b, whereas the product of cyclization 
at C-3 was not isolated at all. There are currently no reports on the synthesis of 2,10-dihydro-
benzo[b][1,7]naphthyridine-1,5-diones (8) or 3H-pyrazino[1,2-a]quinoline-4,6-diones (9). Riepl et 
al. reported the preparation of 5,7-dihydrodibenzo[b,f][1,7]naphthyridine-6,12-diones by a Fischer 
type rearrangement reaction.15 However, the versatility of this methodology was strongly limited by 
the need to use freshly prepared symmetric 1,2-diarylhydrazines. 
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Scheme 2. Synthesis of 10-methyl-2,10-dihydrobenzo[b][1,7]naphthyridine-1,5-dione and 3H-pyrazino[1,2-
a]quinoline-4,6-dione 
 
To evaluate the influence of the chain length on the cyclization, the reactivity of δ- and ε-oxamides 
was investigated as well. 
When the coupling reaction of N-methyl kynurenic acid 5a was carried out with 4-aminobutanol, 
alcohol 10a was obtained (Scheme 3). Oxidation of 10a, followed by treatment with TFA, gave the 
enamide 11a. The same result was obtained when the quinolone nitrogen was protected with a 
benzyl group (compound 11b). 
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This confirmed that the carbonyl group underwent a nucleophilic attack by the amide nitrogen. 
However, unlike the case of indole,6 the lower reactivity of the quinolone ring towards the 
electrophilic substitution prevented the acid-catalyzed intramolecular cyclization and gave rise to 
compounds 11a-b by an elimination reaction.  
Interestingly, oxidation followed by acid treatment of compounds 12a-b, obtained from kynurenic 
acid 5b, gave the new compounds 13a-b (Scheme 3). In this case, a tandem heteroannulation 
reaction - which is most likely due to a first nucleophilic attack of the amide nitrogen to the 
aldehyde, followed by the N-1 attack on the pentaatomic intermediate ring - furnishes a tetracyclic 
fused system.  
As compound 13a showed antitumor activity (IC50 = 10 µM) on H460 tumor cell lines,16 the scope 
of the reaction was explored by preparing differently substituted analogues.  
Accordingly, treatment of kynurenic acid 5b with 2-(2-aminophenyl) ethanol gave the alcohol 14, 
which was oxidized to the corresponding aldehyde, on in its turn converted into the pentacyclic 
derivative 15 by the usual treatment with TFA (Scheme 3). 
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Scheme 3. Synthesis of 4-quinolone fused heterocyclic ring systems 13a-b and 15. 
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Scheme 4. Synthesis of 8,9,10,10a-tetrahydro-7a,10b-diaza-pentaleno[1,2-a]naphthalene-5,7-diones 
 
Compounds 21a-d, bearing substituents on ring A were obtained from the suitable anilines 16a-b 
(Scheme 4). Further elaboration of the bromoderivative 21b via Suzuki-Miyaura palladium-
catalyzed cross-coupling reactions generated compounds 21c and 21d. 
 
3. Conclusions 
 
In conclusion, we have devised a reliable synthetic route to 4-quinolone-based fused systems 
starting from 4-quinolone-2-carboxylic acid oxoamides. The acid-catalyzed intramolecular reaction 
of N-unsubstituted quinolones gives structurally diverse compounds, depending on the length of the 
chain. Acid treatment of β-oxoamides furnishes 3H-pyrazino[1,2-a]quinoline-4,6-diones, due to the 
nucleophilic attack of N-1 to the carbonyl group, whereas acid treatment of δ- and ε-oxoamides 
leads to the formation of tetracyclic compounds by a tandem heteroannulation reaction.  
To the best of our knowledge, no examples of such heterocyclic structures have been reported in the 
literature so far. Therefore, our sequence represents a versatile approach to new biologically 
relevant scaffolds and specifically provides a method for the rapid preparation of differently 
substituted derivatives. 
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4. Experimental section 
 
4.1. General method. All reagents and solvents were reagent grade or were purified by standard 
methods before use. Melting points were determined in open capillaries and are uncorrected. NMR 
spectra were recorded at 300 MHz. Chemical shifts (δ values) and coupling constants (J values) are 
given in ppm and Hz, respectively. Solvents were routinely distilled prior to use; anhydrous 
tetrahydrofuran (THF) and ether (Et2O) were obtained by distillation from sodium-benzophenone 
ketyl; dry methylene chloride was obtained by distillation from phosphorus pentoxide. All reactions 
requiring anhydrous conditions were performed under a positive nitrogen flow, and all glassware 
were oven dried and/or flame dried. Isolation and purification of the compounds were performed by 
flash column chromatography on silica gel 60 (230-400 mesh). Analytical thin-layer 
chromatography (TLC) was conducted on Fluka TLC plates (silica gel 60 F254, aluminum foil).  
Compound 5b was purchased from Sigma-Aldrich. 
 
4.2. Methyl-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid (5a)13  To a solution of N-
methylaniline (0.98 g, 9.15 mmol, 1.01 mL) in H2O (30 mL), DMAD (1.08 g, 7.62 mmol, 0.96 mL) 
was added dropwise and the  reaction was stirred for 2 h at room temperature, then the aqueous 
phase was extracted with EtOAc (3 × 30 mL) and the collected organic layers were dried, filtered 
and evaporated. The crude was purified by flash chromatography. (Hexane/EtOAc from 90:10 to 
85:15) to give 2-(methylphenylamino)but-2-enedioic acid dimethyl ester. Yield 71%; white solid; 
mp =  74 °C; Rf : 0.16 (AcOEt/Hexane 10:90); 1H-NMR (300 MHz, CDCl3) δ: 7.40-7.08 (5H, m), 
4.78 (1H, s), 3.66 (3H, s), 3.63 (3H, s), 3.20 (3H, s); 13C-NMR (75 MHz, CDCl3) δ: 167.4, 164.9, 
153.8, 144,1, 129.0 (× 2), 127.0, 126.1 (× 2), 87.7, 52.2, 50.5, 40.4. Anal.Calcd for C13H15NO4: C, 
62.64; H, 6.07; N, 5.62. Found: C, 62.88; H, 6.04; N, 5.66. 
A solution of 2-(methylphenylamino)-but-2-enedioic acid dimethyl ester (1.16 g,; 4.65 mmol) in 
PPA (2.40 g,; 70.40 mmol) was heated at 80 ° C for 1.5 h. The mixture was added with to ice-water, 
then with a solution of NH4OH (33%) was added. The aqueous phase was extracted with EtOAc (3 
× 50 mL). The collected organic layers were washed with water, dried filtered and evaporated to 
obtain 877 mg of 1-methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid methyl ester as a white 
solid. Yield 87%; mp = 140 °C; Rf : 0.25 (CH2Cl2/MeOH 195:5); 1H-NMR (300 MHz, CDCl3) δ: 
8.44 (1H, d, J = 8.1 Hz), 7.76 (1H, dd, J = 8.1 Hz, J =,  8.1 Hz), 7.57 (1H, d, J = 8.8 Hz), 7.44 (1H, 
dd, J = 8.1 Hz, J = , 8.8 Hz), 6.70 (1H, s), 3.86 (3H, s); 13C-NMR (75 MHz, CDCl3) δ: 177.6, 163.7, 
143.3, 141.5, 132.7, 126.7, 126.2, 123.8, 115.6, 112.0, 53.1, 36.9. Anal.Calcd for C12H11NO3: C, 
66.35; H, 5.10; N, 6.45. Found: C, 66.58; H, 5.13; N, 6.41. 
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To a suspension of 1-methyl-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid methyl ester (857 mg,; 
3.94 mmol) in MeOH (13 mL), 1N NaOH (13 mL) was added. The resulting mixture was refluxed 
heated at reflux for 1 h, then MeOH was evaporated. After cooling with an ice-bath, 1N HCl was 
added and the white solid 5a formed was filtered and dried. Yield 95% ;  mp > 300 ° C; Rf = 0.41 
(CH2Cl2/MeOH 19:1); 1H-NMR (300 MHz, DMSO- d6) δ: 8.13 (1H, d, J = 7.3 Hz), 7.75–7.64 (2H, 
m), 7.35 (1H, m), 5.83 (1H, s), 3.75 (3H, s); 13C-NMR (75 MHz, DMSO-d6) δ: 176.3, 165.7, 152.9, 
140.9, 132.3, 126.2, 125.3, 125.2, 123.4, 117.1, 106.6. Anal.Calcd for C11H9NO3: C, 65.02; H, 4.46; 
N, 6.89. Found: C, 65.33; H, 4.43; N, 6.85. 
 
4.3. 1-Benzyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (5c). To a solution of N-
benzylaniline (1.50 g, 8.19 mmol) in MeOH (36 mL), DMAD (1.15 mL, 9.14 mmol, 1.15 mL) was 
added dropwise and the  reaction was refluxed heated at reflux for 6 h. The solvent was evaporated 
and the crude product was purified by flash chromatography (Hexane/: EtOAc 19:1, then 85:15) to 
give 2-(benzylphenylamino)but-2-enedioic acid dimethyl ester (22) as a white solid (1.89 g, 85%); 
mp = 113 ° C; Rf  : 0.10 (Hexane/EtOAc 90:10); 1H-NMR (300 MHz, CDCl3) δ: 7.48-7.13 (10H, 
m), 4.80 (1H, s), 4.76 (2H, s), 3.72 (3H, s), 3.61 (3H, s); 13C-NMR (75 MHz, CDCl3) δ: 167.4, 
165.0, 153.5, 142.9, 135.3, 129.0 (2C), 128.3 (2C), 127.2 (2C), 127.1 (2C), 126.9 (2C), 88.7, 56.9, 
52.3, 50.5. Anal.Calcd for C19H19NO4: C, 70.14; H, 5.89; N, 4.31. Found: C, 70.38; H, 5.84; N, 
4.34. 
2-(Benzylphenylamino)but-2-enedioic acid dimethyl ester (1.65 g; 5.40 mmol) was dissolved in 
P2O5/CH3SO3H (Eaton’s reagent, 5.72 mL) and the solution was heated at 50-55 °C for 4 h under 
N2. After cooling to 0-5 ° C, it was dropped into a saturated cold solution of Na2CO3 (40 mL). The 
aqueous phase was extracted with EtOAc (3 × 50 mL) and the collected organic layers were dried, 
filtered and evaporated to obtain a crude product that was recrystallized from Et2O. 1-Benzyl-4-
oxo-1,4-dihydroquinoline-2-carboxylic acid methyl ester (23) was obtained as a yellow solid (1.30 
g, 82%); mp = 133 ° C; Rf : 0.22 (CH2Cl2/MeOH 195:5); 1H-NMR (300 MHz, CDCl3) δ: 8.45 (1H, 
d, J = 7.3 Hz), 7.58 (1H, dd, J = 7.3, 8.2 Hz), 7.47-7.28 (5H, m), 7.15 (2H, d, J = 7.3 Hz), 6.77 (1H, 
s), 5.54 (2H, s), 3.90 (3H, s); 13C-NMR (75 MHz, CDCl3) δ: 177.7, 163.7, 143.5, 141.0, 135.5, 
132.7, 128.6, 127.4, 127.0, 126.3, 125.4, 123.9, 116.7, 112.5, 53.1, 52.3. Anal.Calcd for 
C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.56; H, 5.12; N, 4.81. 
The above compound (1.30 g, 4.00 mmol) was suspended in MeOH (13.2 mL). After addition of 
1N NaOH (13.2 mL) the mixture was refluxed heated at reflux for 1h. Methanol was evaporated 
and the solution was cooled with an ice-bath. 2N HCl was added to pH 1-2 and the precipitate was 
filtered to obtain 1.19 g of the title compound as a white solid (1.12 g, 100%); mp = 201 ° C; Rf : 
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0.26 (RP-18 MeOH/H2O 30:70.); 1H-NMR (300 MHz, DMSO-d6) δ: 8.18 (1H, d, J = 7.9 Hz), 7.71-
7.56 (2H, m), 7.43-7.12 (6H, m), 6.43 (1H, s); 13C-NMR (75 MHz, DMSO-d6) δ: 176.4, 164.9, 
147.1, 140.5, 136.6, 133.0, 128.7 (×2), 127.4, 126.8, 126.2, 125.6 (×2), 124.1, 118.1, 109.7, 51.8. 
Anal.Calcd for C17H13NO3: C, 73.11; H, 4.69; N, 5.02. Found: C, 73.28; H, 4.63; N, 5.07. 
 
4.4. General procedure A: synthesis of amides 6, 7, 10, 12, 14, 20. 
To a suspension of the appropriate quinolonecarboxylic acid (1 mmol) in 6 mL of dry THF at 25 ° 
C, HOBt (1.5 mmol), WSC (1.5 mmol) and the appropriate aminoalcohol (1.5 mmol) were added 
sequentially. The mixture was stirred at room temperature under nitrogen, then the solvent was 
evaporated, water was added and the solid formed filtered. The crude product was purified by flash 
chromatography. 
 
4.4.1.1-Methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (2-hydroxyethyl)amide (6a). 
Synthesized from 5a (80 mg, 0.39 mmol) and 2-aminoethanol. Stirred overnight at room 
temperature. Purified by flash chromatography (CH2Cl2 / MeOH 75:25). White solid (83 mg, 85%); 
mp = 62 °C; Rf : 0.29 (CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, MeOD) δ: 8.28 (1H, d, J = 7.9 
Hz), 7.84-7.75 (2H, m), 7.47 (1H, m), 6.35 (1H, s), 3.83 (3H, s), 3.73 (2H, t, J = 5.8 Hz), 3.52 (2H, 
t, J = 5.8 Hz); 13C-NMR (75 MHz, MeOD) δ: 176.7, 162.8, 148.3, 139.4, 131.3, 124.1, 123.4, 
122.4, 114.7, 105.9, 57.8, 40.0, 34.3. Anal.Calcd for C13H14N2O3: C, 63.40; H, 5.73; N, 11.38. 
Found: C, 63.50; H, 5.77; N, 11.34. 
 
4.4.2. 4-Oxo-1,4-dihydroquinoline-2-carboxylic acid (2-hydroxyethyl)amide (6b). Synthesized from 
kynurenic acid (200 mg, 1.04 mmol) and aminoethanol. Stirred overnight at room temperature. 
Purified by flash chromatography (CH2Cl2 / MeOH 90:10). White solid (193 mg, 80%); mp = 252 ° 
C; Rf : 0.26 (CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, DMSO-d6 + TFA) δ: 9.03 (1H, t, J = 6.1 
Hz), 8.10 (1H, d, J = 8.2 Hz), 7.99 (1H, d, J = 8.2 Hz), 7.72 (1H, dd, J = 8.2, 8.2 Hz), 7.41 (1H, dd, 
J = 8.2, 8.2 Hz), 6.92 (1H, s), 3.55 (2H, t, J = 6.1 Hz), 3.38 (2H, q, J = 6.1 Hz); 13C-NMR (75 MHz, 
DMSO-d6 + TFA) δ: 175.1, 162.1, 143.3, 140.8, 132.3, 124.4, 124.2, 120.8, 105.9, 59.3, 42.4. 
Anal.Calcd for C12H12N2O3: C, 62.06; H, 5.21; N, 12.06. Found: C, 62.21; H, 5.27; N, 12.03. 
 
4.4.3.1-Methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (2,2-diethoxyethyl)amide (7a). 
Synthesized from 5a (250 mg, 1.23 mmol) and aminoacetaldehyde diethylacetal. Stirred 3 h at room 
temperature. Purified by crystallization from diethyl ether. White solid (346 mg, 88%); mp = 136 ° 
C; Rf = 0.66 (CH2Cl2/ MeOH 90:10); 1H-NMR (300 MHz, DMSO-d6) δ: 9.09 (1H, t, J = 5.2 Hz), 
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8.18 (1H, d, J = 8.5 Hz), 7.85-7.76 (2H, m), 7.45 (1H, m), 6.03 (1H, s), 4.67 (1H, t, J = 5.2 Hz), 
3.72 (3H, s), 3.69-3.30 (6H, m), 1.15 (6H, t, J = 7.0 Hz); 13C-NMR (75 MHz, DMSO-d6) δ: 176.2, 
163.6, 149.6, 141.0, 132.8, 126.3, 125.4, 123.8, 117.2, 107.9, 99.6, 61.4, 41.5, 36.5, 15.3. 
Anal.Calcd for C17H22N2O4: C, 64.13; H, 6.97; N, 8.80. Found: C, 63.89; H, 6.95; N, 8.78. 
4.4.4. 4-Oxo-1,4-dihydroquinoline-2-carboxylic acid (2,2-diethoxyethyl)amide (7b). Synthesized 
from kynurenic acid (260 mg, 1.35 mmol) and aminoacetaldehyde diethylacetal. Stirred 3 h at room 
temperature. White solid (343 mg, 83%); mp =  226 ° C; Rf : 0.57 (CH2Cl2/MeOH 90:10); 1H-NMR 
(300 MHz, DMSO-d6 + TFA) δ: 9.11 (1H, t, J = 5.5 Hz), 8.10 (1H, d, J = 8.2 Hz), 7.98 (1H, d, J = 
8.2 Hz), 7.72 (1H, dd, J = 8.2, 8.2 Hz), 7.41 (1H, dd, J = 8.2,  Hz, J = 8.2 Hz), 6.91 (1H, s), 4.65 
(1H, t, J = 5.5 Hz), 3.65 (2H, m), 3.50 (2H, m), 3.40 (2H, t, J = 5.5 Hz), 1.15 (6H, t, J = 7.0 Hz); 
13C-NMR (75 MHz, DMSO-d6 + TFA) δ: 174.8, 162.3, 143.2, 141.0, 132.3, 124.5, 124.4, 124.1, 
121.0, 105.9, 99.8, 61.3, 42.3, 15.3. Anal.Calcd for C16H20N2O4: C, 63.14; H, 6.62; N, 9,20. Found: 
C, 63.34; H, 6.59; N, 9,23. 
 
4.4.5. 1-Methyl-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (4-hydroxybutyl)amide (10a). 
Synthesized from 5a (300 mg, 1.48 mmol) and 4-aminobutanol. Refluxed Heated at reflux for 2 h. 
Purified by flash column chromatography (CH2Cl2/MeOH 95:5). White solid (349 mg, 86%); mp = 
138 ° C; Rf : 0.44 (CH2Cl2/MeOH 80:20); 1H-NMR (300 MHz, DMSO-d6) δ: 9.02 (1H, t, J = 5.5 
Hz), 8.18 (1H, d, J = 7.9 Hz), 7.83-7.75 (2H, m), 7.44 (1H, m), 6.06 (1H, s), 4.47 (1H, t, J = 5.5 
Hz), 3.70 (3H, s), 3.49-3.39 (2H, m, 2H), 3.32-3.29 (2H, m, 2H), 1.63-1.44 (m, 4H, m); 13C-NMR 
(75 MHz, DMSO-d6) δ: 176.3, 163.3, 149.8, 141.1, 132.8, 126.4, 125.4, 123.8, 117.2, 108.0, 60.4, 
1C overlapped to the solvent signal, 36.5, 29.9, 25.4. Anal.Calcd for C15H18N2O3: C, 65.68; H, 6.61; 
N, 10.21. Found: C, 65.44; H, 6.63; N, 10.23. 
 
4.4.6. 1-Benzyl-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid (4-hydroxy-butyl)-amide (10b). 
Synthesized from 5c (600 mg, 2.15 mmol) and 4-aminobutanol. Stirred overnight at room 
temperature. Purified by flash column chromatography (CH2Cl2/MeOH 95:5). White solid (457 mg, 
61%); mp = 175 ° C; Rf : 0.47 (CH2Cl2/MeOH 16:4); 1H-NMR (300 MHz, DMSO-d6) δ: 9.15 (1H, 
t, J = 5.8 Hz), 8.18 (1H, d, J = 7.9 Hz), 7.55-7.70 (2H, m), 7.41-7.17 (6H, m), 6.18 (1H, s), 5.52 
(2H, s), 4.40 (1H, t, J = 5.2 Hz), 3.40-3.28 (2H, m), 3.26-3.14 (2H, m), 1.54-1.30 (4H, m); 13C-
NMR (75 MHz, DMSO-d6) δ: 176.4, 163.4, 150.0, 140.3, 136.5, 132.7, 128.6 (×2), 127.4, 126.7 
(×2), 126.4, 125.6, 123.9, 118.0, 108.7, 60.3, 51.1, 29.8, 25.3. Anal.Calcd for C21H22N2O3: C, 
71.98; H, 6.33; N, 7.99. Found: C, 72.13; H, 6.30; N, 8.01. 
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4.4.7. 4-Ooxo-1,4-dihydroquinoline-2-carboxylic acid (4-hydroxybutyl)amide (12a). Synthesized 
from kynurenic acid 5b (300 mg, 1.55 mmol) and 4-aminobutanol. Stirred overnight at room 
temperature. Purified by flash chromatography (CH2Cl2 / MeOH 90:10). White solid (326 mg, 
81%); mp = 225-227 ° C; Rf : 0.58 (CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, DMSO- d6 + TFA) 
δ: 9.14 (1H, t, J = 6.1 Hz), 8.14 (1H, d, J = 8.5 Hz), 8.04 (1H, d, J = 8.5 Hz), 7.77 (1H, dd, J = 8.5, 
8.5 Hz), 7.47 (1H, dd, J = 8.5, 8.5 Hz), 6.96 (1H, s), 3.45 (2H, t, J = 6.4 Hz), 3.33 (2H, m), 1.58 
(2H, m), 1.49 (2H, m); 13C-NMR (75 MHz, DMSO- d6 + TFA) δ: 174.9, 161.3, 143.7, 140.3, 132.9, 
125.0, 124.1, 123.9, 120.6, 105.6, 60.4, 29.9, 25.5. Anal.Calcd for C14H16N2O3: C, 64.60; H, 6.20; 
N, 10.76. Found: C, 64.53; H, 6.23; N, 10.74. 
 
4.4.8. 4-Ooxo-1,4-dihydroquinoline-2-carboxylic acid (5-hydroxypentyl)amide (12b). Synthesized 
from kynurenic acid 5b (500 mg, 2.59 mmol) and 5-aminopentanol. Stirred overnight at room 
temperature. Purified by flash chromatography (CH2Cl2/MeOH 75:25). Yellow solid (670 mg, 
94%); mp = 233 ° C; Rf : 0.40 (CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, DMSO -d6 ) δ: 11.83 
(1H, s), 9.02 (1H, s), 8.07 (1H, m), 7.96 (1H, m), 7.71 (1H, m), 7.36 (1H, m), 6.71 (1H, s), 4.39 
(1H, s), 3.46-3.26 (4H, m, overlapped to H2O signal), 1.65-1.25 (6H, m); 13C-NMR (75 MHz, 
DMSO- d6 + TFA) δ: 175.4, 161.6, 143.4, 140.5, 132.6, 124.6, 124.3, 124.2, 120.5, 105.9, 60.6, (1 
signal overlapped to the solvent signal), 32.2, 28.6, 23.0. Anal.Calcd for C15H18N2O3: C, 65.68; H, 
6.61; N, 10.21. Found: C, 65.44; H, 6.63; N, 10.19. 
 
4.4.9. 4-Oxo-1,4-dihydroquinoline-2-carboxylic acid [2-(2-hydroxyethyl)phenyl]amide (14). 
Synthesized from kynurenic acid 5b (500 mg, 2.59 mmol) and 2-aminophenyl alcohol. Stirred 
overnight at room temperature. Purified by flash chromatography (CH2Cl2/MeOH 195:5), then 
crystallized from MeOH. White solid (462 mg, 58%); mp = 248 ° C; Rf : 0.25 (CH2Cl2/MeOH 
90:10); 1H-NMR (300 MHz, DMSO -d6 + TFA) δ: 8.16 (1H, d, J = 8.2 Hz), 8.05 (1H, d, J = 8.2 
Hz), 7.76 (1H, m), 7.67 (1H, d, J = 7.9 Hz), 7.47 (1H, m), 7.37-7.16 (3H, m), 7.13 (1H, s), 3.70 
(2H, t, J = 6.4 Hz), 2.83 (2H, t, J = 6.4 Hz); 13C-NMR (75 MHz, DMSO -d6 + TFA) δ: 173.9, 161.2, 
144.7, 142.1, 135.8, 134.3, 132.1, 130.5, 126.7, 126.0, 125.0, 124.1, 123.9, 122.4, 105.4, 62.0, 34.8. 
Anal.Calcd for C19H18N2O3: C, 70.79; H, 5.63; N, 8.69. Found: C, 70.88; H, 5.60; N, 8.66. 
 
4.4.10. 5,6,7-Trimethoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (4-hydroxybutyl) amide 
(20a). Synthesized from 19a (220 mg, 0.79 mmol) and 4-aminobutanol. Refluxed Heated at reflux 2 
h, then overnight at rt. Purified by flash chromatography (CH2Cl2/MeOH 95:5). White solid (149 
mg, 54%); mp = 77 ° C; Rf : 0.2 (CH2Cl2/MeOH 95:5); 1H-NMR (300 MHz, DMSO-d6 + TFA) δ: 
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9.23 (1H, t, J = 6.1 Hz), 7.56 (1H, s), 7.15 (1H, s), 3.94 (3H, s), 3.86 (3H, s), 3.82 (3H, s), 3.43 (2H, 
t, J = 6.1 Hz), 3.33 (2H, q, J = 6.1 Hz), 1.66-1.42 (4H, m); 13C-NMR (75 MHz, DMSO-d6 + TFA) 
δ: 171.2, 160.4, 158.4, 149.8, 143.6, 141.5, 139.8, 112.3, 104.6, 97.5, 62.1, 61.1, 60.3, 56.3, 1 signal 
overlapped to the solvent signal, 29.8, 25.4. Anal.Calcd for C17H22N2O6: C, 58.28; H, 6.33; N, 8.00. 
Found: C, 58.45; H, 6.30; N, 7.97. 
 
4.4.11. 6-Bromo-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid (4-hydroxybutyl)-amide (20b). 
Synthesized according to the general procedure A from 19b (497 mg, 1.83 mmol) and 4-
aminobutanol. Heated at rRefluxed for 3 h.; White solid (460 mg, 74%); mp = 190 °C; Rf : 0.47 
(CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz,  DMSO-d6 + TFA) δ: 9.02 (1H, t, J = 5.5 Hz), 8.16 
(1H, d, J = 1.5 Hz), 7.96-7.80 (2H, m), 6.85 (1H, s), 3.42 (2H, t, J = 5.5 Hz), 3.31 (2H, q, J = 5.5 
Hz), 1.65-1.40 (4H, m); 13C-NMR (75 MHz, DMSO-d6 + TFA) δ: 174.7, 161.7, 143.2, 139.6, 
134.9, 126.6, 126.3, 123.1, 116.9, 106.6, 60.4, 1 signal overlapped to the solvent signal, 29.9, 25.5. 
Anal.Calcd for C14H15BrN2O3: C, 49.57; H, 4.46; N, 8.26; Found: C, 49.74; H, 4.44; N, 8.29. 
 
4.5. 10-Methyl-2,10-dihydrobenzo[b][1,7]naphthyridine-1,5-dione (8). Trifluoroacetic acid (297 
μL, 1.26 mmol) was added to a suspension of 7a (200 mg, 0.63 mmol) in 12 mL of CH3CN and the 
mixture was heated at refluxrefluxed for 18 h. The solvent was evaporated, the residue was 
dissolved in EtOAc, washed with sat. aq. NaHCO3 solution and dried over Na2SO4. Purification by 
flash column chromatography (CH2Cl2/ MeOH 95:5). Yellow solid (107 mg, 75%); mp = 237 ° C; 
Rf : 0.30 (CH2Cl2/MeOH 95:5); 1H-NMR (300 MHz, MeOD) δ: 8.35 (1H, d, J = 9.1 Hz), 7.95-7.79 
(3H, m), 7.41 (1H, t, J = 6.4 Hz), 7.18-7.04 (2H, m), 4.36 (3H, s); 13C-NMR (150 MHz, MeOD) δ: 
178.5, 161.2, 145.5, 136.7, 135.6, 128.2, 127.3, 126.8, 124.8, 124.5, 118.3, 102.7, 38.8. Anal.Calcd 
for C13H10N2O2: C, 69.02; H, 4.46; N, 12.38. Found: C, 69.30; H, 4.49; N, 12.36. 
 
4.6. 3H-Pyrazino[1,2-a]quinoline-4,6-dione (9). Trifluoroacetic acid (600 μL) was added to a 
suspension of 7b (400 mg, 1.31 mmol) in 24 mL of CH3CN and the mixture was heated at 
refluxrefluxed for 14 h. The resulting solution was allowed to cool to room temperature and the 
solid formed was filtered, washed with cold ether and dried to give the desired product. Yellow 
solid (217 mg, 78%); mp = 254-255 ° C; Rf : 0.43 (CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, 
DMSO-d6) δ: 11.64 (1H, brs), 8.43 (1H, d, J = 8.8 Hz), 8.32 (1H, d, J = 7.9 Hz), 7.99-7.87 (2H, m), 
7.65 (1H, m), 7.10 (1H, s), 6.90 (1H, t, J = 5.5 Hz); 13C-NMR (75 MHz, DMSO-d6) δ: 173.8, 156.1, 
139.9, 137.1, 133.4, 126.6, 126.4, 125.5, 117.3, 114.6, 106.4, 106.2. Anal.Calcd for C12H8N2O2: C, 
67.92; H, 3.80; N, 13.20. Found: C, 67.64; H, 3.83; N, 13.18. 
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4.7. General procedure B: oxidation of compounds 10, 14, 20 with IBX in EtOAc followed by 
TFA-catalyzed cyclization to give compounds 11, 15, 21 
To a suspension of the appropriate alcohol (1 mmol) in EtOAc (30 mL), IBX (3 mmol) was added. 
The mixture was heated at refluxrefluxed for 1-10 h. IBX in excess was filtered through a medium 
glass frit and the filter cake was washed with hot EtOAc (2 × 30 ml). The combined filtrates were 
concentrated to give a crude product that was used without further purification.  
Trifluoroacetic acid (470 μL) was added to a suspension of the carbonyl compound (1 mmol) in 19 
mL of CH3CN and the mixture was heated at refluxrefluxed for 1-18 h. The solvent was evaporated, 
the residue was dissolved in EtOAc, washed with sat. aq. NaHCO3 solution and dried over Na2SO4. 
Evaporation of the extract gave a crude product that was purified by flash column chromatography.  
 
4.7.1. 2-(2,3-Dihydropyrrole-1-carbonyl)-1-methyl-1H-quinolin-4-one (11a).  Compound 10a (342 
mg, 1.25 mmol) was heated at refluxrefluxed for 1 h with IBX to give 1-methyl-4-oxo-1,4-
dihydroquinoline-2-carboxylic acid (4oxobutyl)amide; Rf : 0.24 (CH2Cl2/MeOH 185:15).  
The above aldehyde was refluxed heated at reflux for 2 h with TFA. Purification by flash column 
chromatography (CH2Cl2/MeOH 195:5-190:10) afforded the title compound. White solid (113 mg, 
75%); mp = 118 ° C; Rf : 0.36 (CH2Cl2/MeOH 185:15); 1H-NMR (300 MHz, DMSO-d6). 2 
rotamers (ratio 1:0.2) First rotamer δ: 8.19 (1H, d, J = 7.9 Hz), 7.83-7.73 (2H, m), 7.45 (1H, m), 
6.54 (1H, m), 6.02 (1H, s), 5.39 (1H, m), 3.96 (2H, t, J = 8.8 Hz), 3.65 (3H, s), 2.69 (2H, m). 
Second rotamer δ: 8.19 (1H, d, J = 7.9 Hz), 7.83-7.73 (2H, m), 7.45 (1H, m), 6.99 (1H, m), 6.16 
(1H, s), 5.61 (1H, m), 3.77 (2H, t, J = 8.8 Hz), 3.70 (3H, s), 2.69 (2H, m); 13C-NMR (75 MHz, 
DMSO-d6) δ: 176.1, 159.0, 148.3, 141.1, 132.7, 129.1, 127.7, 126.5, 126.4, 125.4, 123.9, 117.3, 
115.7, 115.2, 114.5, 107.6, 106.8, 46.6, 44.8, 37.1, 36.4, 29.5, 28.1; GC-MS (EI) m/z (%) 254 (30), 
168 (78), 89 (100). Anal.Calcd for C15H14N2O2: C, 70.85; H, 5.55; N, 11.02. Found: C, 70.99; H, 
5.57; N, 11.00. 
 
4.7.2. 1-Benzyl-2-(2,3-dihydropyrrole-1-carbonyl)-1H-quinolin-4-one (11b). Compound 10b (447 
mg, 1.27 mmol) was heated at refluxrefluxed for 3 h with IBX to give 1-benzyl-4-oxo-1,4-
dihydroquinoline-2-carboxylic acid (4-oxobutyl)amide; light yellow solid; Rf : 0.24 (CH2Cl2/MeOH 
185:15).  
The above aldehyde was heated at refluxrefluxed for 3.5 h with TFA. Purification by flash column 
chromatography (CH2Cl2/MeOH 195:5 - 192:8) afforded the title compound. White solid (88 mg, 
21%); mp = 137-139 ° C; Rf : 0.52 (CH2Cl2/MeOH 18:2); 1H-NMR (300 MHz, DMSO-d6) 2 
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rotamers (ratio 1:0.3) First rotamer: δ: 8.20 (1H, dd, J = 8.2, 1.8 Hz ), 7.71-7.55 (2H, m), 7.44-7.15 
(6H, m), 6.55 (1H, m), 6.13 (1H, s), 5.57-5.26 (3H, m), 3.82 (2H, m), 2.61 (2H, m); Second 
rotamer: δ: 8.20 (1H, dd, J = 8.2, 1.8 Hz ), 7.71-7.55 (2H, m), 7.44-7.15 (6H, m), 6.91 (1H, m), 6.28 
(1H, s), 5.57-5.26 (3H, m), 3.82 (2H, m), 2.61 (2H, m); 13C-NMR (75 MHz, DMSO-d6) δ: 176.2, 
176.1, 158.8, 158.5, 148.5, 148.4, 140.5, 140.4, 136.2, 136.0, 132.8, 132.7, 132.6, 129.13, 129.1, 
128.7, 127.7, 127.6, 127.5, 126.9, 126.4, 125.7, 125.6, 124.0, 123.9, 118.0, 116.1, 115.6, 114.4, 
108.3, 108.2, 107.7, 51.5, 51.3, 46.8, 44.8, 29.5, 28.0; GC-MS (EI) m/z (%) 330 (10), 234 (35), 91 
(100). Anal.Calcd for C21H18N2O2: C, 76.34; H, 5.49; N,. 8.48. Found: C, 76.12; H, 5.44; N,. 8.45. 
 
4.7.3. 1,10-Diazapentacyclo[10.8.0.02,10.04,9.015,20]icosa-4,6,8,12,15(20),16,18-heptaene-11,14-
dione (15). Compound 14 (265 mg, 0.86 mmol) was heated at refluxrefluxed for 7 h with IBX to 
give 4-oxo-1,4-dihydroquinoline-2-carboxylic acid 2-(2-oxoethyl)benzylamide; white solid; Rf : 
0.46 (CH2Cl2/MeOH 19:1).  
The above aldehyde was heated at reflux refluxed for 1 h with TFA to give the title compound. 
Purified by flash chromatography (CH2Cl2/MeOH 195:5). White solid (210 mg, 85%); mp = 257 ° 
C; Rf : 0.25 (CH2Cl2/MeOH 19:1); 1H-NMR (300 MHz, MeOD) δ: 8.36 (1H, d, J = 7.9 Hz), 7.91 
(1H, m), 7.75 (1H, d, J = 8.5 Hz), 7.67-7.52 (2H, m), 7.45-7.31 (2H, m), 7.25 (1H, m), 6.80 (1H, 
m), 6.72 (1H, s), 4.05 (1H, m), 3.48 (1H, m); 13C-NMR (75 MHz, DMSO) δ: 177.5, 161.3, 142.9, 
137.8, 136.9, 133.7, 133.2, 128.1, 126.5, 126.3, 126.2, 126.18, 124.9, 116.3, 116.0, 103.9, 78.8, 
34.7. Anal.Calcd for C18H12N2O2: C, 74.99; H, 4.20; N, 9.72. Found: C, 74.75; H, 4.22; N, 9.76. 
 
4.7.4. 2,3,4-Trimethoxy-8,9,10,10a-tetrahydro-7a,10b-diazapentaleno[1,2-a]naphthalene-5,7-dione 
(21a). Compound 20a (107 mg, 0.31 mmol) was heated at refluxrefluxed for 6 h with IBX to give 
5,6,7-trimethoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (3-oxopropyl)amide as a yellow 
solid; Rf : 0.16 (CH2Cl2/MeOH 195:5).  
The above aldehyde was heated at refluxrefluxed for 2 h with TFA. Purified by flash 
chromatography (CH2Cl2/MeOH 95:5). Yellow solid (64 mg, 68%); mp = 108 ° C; Rf  : 0.35 
(DCM/MeOH 95:5); 1H-NMR (300 MHz, MeOD) δ: 6.85 (1H, s), 6.61 (1H, s), 6.12 (1H, m), 4.08 
(3H, s), 3.93 (3H, s), 3.89 (3H, s), 3.84 (1H, m), 3.50 (1H, m), 2.88 (1H, m), 2.52-2.39 (2H, m), 
1.70 (1H, m); 13C-NMR (75 MHz, MeOD) δ: 178.8, 164.6, 160.6, 154.4, 143.4, 142.6, 137.5, 115.8, 
104.9, 94.6, 80.1, 62.8, 61.9, 57.3, 42.9, 30.8, 26.9. Anal.Calcd for C17H18N2O5: C, 61.81; H, 5.49; 
N, 8.48. Found: C, 62.04; H, 5.47; N, 8.46. 
4.7.5. 3-Bromo-8,9,10,10a-tetrahydro-7a,10b-diazapentaleno[1,2-a]naphthalene-5,7-dione (21b). 
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Compound 20b (453 mg, 1.33 mmol).was heated at refluxrefluxed for 9 h  with IBX to give 6-
bromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (4-oxobutyl)amide as a yellow solid; Rf : 0.46 
(CH2Cl2/MeOH 19:1).  
The above aldehyde was heated at refluxrefluxed for 1 h with TFA. Purified by flash 
chromatography (CH2Cl2/MeOH 95:5). White solid (292 mg, 69%); mp = 263 ° C; Rf : 0.32. 
(DCM/MeOH 195:5); 1H-NMR (600 MHz, DMSO-d6) δ: 8.27 (1H, d, J = 2.3 Hz), 7.98 (1H, dd, J = 
2.3, 8.9 Hz), 7.72 (1H, d, J = 8.9 Hz), 6.37 (1H, s), 6.09-6.02 (1H, m), 3.73-3.63 (1H, m), 3.43-3-36 
(1H, m), 2.79-2.68 (1H, m), 2.36-2.19 (2H, m), 1.73-1.60 (1H, m); 13C-NMR (150 MHz, DMSO-
d6) δ: 175.5, 162.6, 142.7, 135.4, 135.1, 127.7, 127.1, 118.4, 117.0, 102.7, 77.1, 41.1, 28.7, 25.0. 
Anal.Calcd for C14H11BrN2O2: C, 52.69; H, 3.47; N, 8.78. Found: C, 52.55; H, 3.45; N, 8.76. 
 
4.7.5. 8,9,10,10a-Tetrahydro-7a,10b-diaza-pentaleno[1,2-a]naphthtalene-5,7-dione (13a). To a 
solution of IBX (135 mg, 0.50 mmol) in DMSO (0.68 mL) compound 12a (65 mg, 0.25 mmol) was 
added and the mixture was stirred overnight at rt under nitrogen. The mixture was diluted with sat. 
aq. NaHCO3 (2 mL). The solid formed was filtered and dried to give 4-oxo-1,4-dihydroquinoline-2-
carboxylic acid (4-oxobutyl)amide as a white solid; Rf : 0.43 (CH2Cl2/MeOH 90:10). The 
compound was used without further purification.  
Trifluoroacetic acid (177 μL) was added to a suspension of the above aldehyde (100 mg, 0.39 
mmol) in 7 mL of CH3CN and the mixture was heated at refluxrefluxed for 3 h. The solvent was 
evaporated, the residue was dissolved in EtOAc, washed with sat. aq. NaHCO3 solution and dried 
over Na2SO4. Evaporation of the extract gave a crude product that was purified by crystallization  
from Et2O to give the title compound as a white solid (33.8 mg, 64%). mp = 172 ° C; Rf : 0.56 
(CH2Cl2/MeOH 90:10); 1H-NMR (300 MHz, DMSO- d6) δ: 8.20 (1H, d, J = 8.2 Hz), 7.83 (1H, dd, 
J = 8.2, Hz, J =  8.2 Hz), 7.72 (1H, d, J = 8.2 Hz), 7.49 (1H, dd, J = 8.2 Hz,,  8.2 Hz), 6.33 (1H, s), 
6.15-6.00 (1H, m), 3.769-3.60 (1H, m), 3.39 46-3.33 (1H, m), 2.8985-2.70 (1H, m), 2.37-2.21 (2H, 
m), 1.78-1.5866 (1H, m); 13C-NMR (75 MHz, DMSO- d6) δ: 177.7, 163.8, 143.2, 137.4, 133.4, 
126.7, 126.5, 125.0, 116.6, 103.3, 77.9, 42.0, 29.9, 26.0; GC-MS (EI) m/z (%) 240 (52), 143 (100), 
88 (28). Anal.Calcd for C14H12N2O2: C, 69.99; H, 5.03; N, 11.66. Found: C, 70.11; H, 5.06; N, 
11.62. 
 
4.7.6. 9,10,11,11a-Tetrahydro-8H-7a,11b-diazabenzo[c]fluorene-5,7-dione (13b). To a solution 
of IBX (394 mg, 1.46 mmol) in DMSO (2 mL) compound 12b (200 mg, 0.73 mmol) was added and 
the mixture was stirred overnight at rt under nitrogen. The mixture was diluted with sat. aq. 
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NaHCO3 (2 mL). The solid formed was filtered and dried to give to give 4-oxo-1,4-
dihydroquinoline-2-carboxylic acid (5-oxopentyl)amide as a white solid; mp = 190 ° C.  
Trifluoroacetic acid (175 μL) was added to a suspension of the above aldehyde (100 mg, 0.37 
mmol) in 7 mL of CH3CN and the mixture was heated at refluxrefluxed for 1 h. The solvent was 
evaporated, the residue was dissolved in EtOAc, washed with sat. aq. NaHCO3 solution and dried 
over Na2SO4. Evaporation of the extract gave a crude product that was purified by flash column 
chromatography .  
 (CH2Cl2/MeOH 19:1). White solid (62 mg, 66%); mp = 181 ° C; Rf : 0.23 (CH2Cl2/MeOH 195:5); 
1H-NMR (300 MHz, MeOD) δ: 8.33 (1H, d, J = 7.3 Hz), 7.94-7.75 (2H, m), 7.652-7.50 (1H, m), 
6.67 (1H, s), 5.92 (1H, dd, J = 7.6, 3.0 Hz), 4.58-4.426 (1H, m), 3.30-3.20 (1H, m), 3.05-2.95 92 
(1H, m), 2.18-2.05 00 (m, 1H), 1.98-1.79 (2H, m), 1.65-1.53 50 (1H, m), 1.45-1.31 29 (1H, m);13C-
NMR (75 MHz, MeOD) δ: 177.6, 156.6, 139.9, 134.8, 131.2, 124.4, 123.0, 122.6, 113.8, 101.1, 
71.1, 38.3, 31.0, 22.8, 19.5. Anal.Calcd for C15H14N2O2: C, 70.85; H, 5.55; N, 11.02. Found: C, 
70.98; H, 5.52; N, 11.05. 
 
4.7.7. 2-(3,4,5-Trimethoxyphenylamino)but-2-enedioic acid diethyl ester (17a). To a solution of 
3,4,5-trimethoxyaniline (1.5 g, 8.02 mmol) in EtOH (27 mL), DEAD (diethylacetylene 
dicarboxylate) (8.03 mmol, 1.35 mL) was added dropwise and the  reaction was heated at 
refluxrefluxed for 3 h. The solvent was evaporated and the crude product was purified by flash 
chromatography (Hexane/EtOAC 80:20). Yellow solid (1.88 g, 66%); mp = 64-66 ° C; Rf : 0.32 
(Hexane/EtOAc 80:20); 1H-NMR (300 MHz, DMSO-d6) δ: 9.59 (1H, s), 6.18 (2H, s), 5.33 (1H, s), 
4.22-4.12 (4H, m), 3.81 (9H, s), 1.30 (3H, t, J = 7.3 Hz), 1.13 (3H, t, J = 7.3 Hz); 13C-NMR (75 
MHz, DMSO-d6) δ: 169.5, 164.5, 153.5, 148.7, 136.5, 135.04, 98.9, 93.4, 62.0, 60.9, 59.9, 56.0, 
14.3, 13.7. Anal.Calcd for C17H23NO7: C, 57.78; H, 6.56; N, 3.96. Found: C, 57.95; H, 6.51; N, 
3.92. 
 
4.7.8. 2-(4-Bromophenylamino)but-2-enedioic acid diethyl ester (17b). To a solution of 4-
bromoaniline (1.5 g, 8.46 mmol) in EtOH (27 mL), DEAD (8.46 mmol, 1.47 mL) was added 
dropwise and the  reaction was heated at refluxrefluxed for 5 h. Purified by flash chromatography 
(Hexane/EtOAc 195:5). Yellow oil (1.87 g, 64%); Rf : 0.63 (Hexane/EtOAc 80:20); 1H-NMR (300 
MHz, CDCl3) δ: 9.61 (1H, brs), 7.38 (2H, d, J = 8.8 Hz), 6.79 (2H, d, J = 8.8 Hz), 5.45 (1H, s), 
4.25-4.13 (4H, m), 1.31 (3H, t, J = 7.0 Hz), 1.15 (3H, t, J = 7.0 Hz); 13C-NMR (75 MHz, CDCl3) δ: 
169.0, 163.6, 147.2, 139.2, 131.6 (x× 2) , 122.1 (×x 2), 116.6, 94.6, 61.8, 59.7, 13.9, 13.3. 
Anal.Calcd for C14H16BrNO4: C, 49.14; H, 4.71; N, 4.09. Found: C, 49.37; H, 4.73; N, 4.11. 
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4.7.9. 5,6,7-Trimethoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid ethyl ester (18a). To a 
7.7% solution of P2O5 in methanesulfphonic acid (3 mL, Eaton Reagent), compound 17a (1g, 2.83 
mmol) was added and the resulting mixture was heated at 55 °C for 1 h. After cooling, the solution 
was dropped into a cold Na2CO3 saturated solution. The precipitate was filtered under vacuum, to 
obtain the title compound as a white solid. (870 mg, 100%); mp = 235 ° C; Rf : 0.34 
(CH2Cl2/MeOH 19:1); 1H-NMR (300 MHz, DMSO-d6) δ: 7.17 (1H, s), 6.62 (1H, s), 4.32 (2H, q, J 
= 7.3 Hz), 3.86 (3H, s), 3.77 (3H, s), 3.75 (3H, s), 1.31 (3H, t, J = 7.3 Hz); 13C-NMR (75 MHz, 
DMSO-d6) δ: 173.9, 164.8, 155.3, 150.8, 144.3, 142.0, 139.0, 116.1, 109.5, 101.0, 61.8, 61.3, 60.9, 
55.7, 14.1. Anal.Calcd for C15H17NO6: C, 58.63; H, 5.58; N, 4.56. Found: C, 58.97; H, 5.54; N, 
4.53. 
 
4.7.10. 6-Bromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid ethyl ester (18b). To a 7.7% 
solution of P2O5 in methanesulfphonic acid (4 mL, Eaton Reagent), compound 17b (1.3 g, 3.79 
mmol) was added and the resulting mixture was heated at 55 °C for 1 h. After cooling, the solution 
was dropped into a cold Na2CO3 saturated solution. The precipitate was filtered under vacuum, to 
obtain the title compound as a white solid. (688 mg, 61%); mp = 255-260 ° C; Rf : 0.57 
(CH2Cl2/MeOH 195:5); 1H-NMR (300 MHz, DMSO-d6) δ: 12.2 (1H, brs), 8.13 (1H, s), 7.94-7.79 
(2H, m), 6.68 (1H, s), 4.40 (2H, q, J = 6.8 Hz), 1.34 (3H, t, J = 6.8 Hz); 13C-NMR (75 MHz, 
DMSO-d6) δ: 175.7, 162.1, 139.3, 138.8, 135.2, 127.1, 126.7, 122.6, 117.0, 110.1, 62.7, 13.9. 
Anal.Calcd for C12H10BrNO3: C, 48.67; H, 3.40; N, 4.73. Found: C, 48.41; H, 3.38; N, 4.70. 
 
4.7.11. 5,6,7-Trimethoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (19a) To a suspension 
of 18a (400 mg,; 1.30 mmol) in EtOH (4.29 mL), 1N NaOH (4.29 mL) was added. The resulting 
mixture was refluxed heated at reflux for 1 h, then EtOH was evaporated. After cooling with an ice-
bath, 1N HCl was added and the white solid formed was filtered and dried .(233 mg, 64%) ; mp = 
234 ° C: Rf : 0.7 (MeOH/H2O 40:60); 1H-NMR (300 MHz, DMSO-d6) δ: 7.39 (1H, s), 6.49 (1H, s), 
3.90 (3H, s), 3.69 (6H, s); 13C-NMR (75 MHz, DMSO-d6) δ: 175.7, 163.7, 156.7, 151.5, 139.5, 
139.2, 137.7, 115.1, 110.7, 97.0, 61.8, 61.0, 55.8. Anal.Calcd for C13H13NO6: C, 55.91; H, 4.69; N, 
5.02. Found: C, 55.79; H, 4.63; N, 5.06. 
 
4.7.12. 6-Bromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid (19b). To a suspension of 18b 
(628 mg,; 2.12 mmol) in EtOH (7.0 mL), 1N NaOH (7.0 mL) was added. The resulting mixture was 
heated at refluxrefluxed for 1.5 h, then EtOH was evaporated. After cooling with an ice-bath, 1N 
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HCl was added and the white solid formed was filtered and dried .(525 mg, 92%); mp >300 ° C; Rf : 
0.76 (RP-18 MeOH/H2O 15:85); 1H-NMR (300 MHz, DMSO-d6) δ: 12.2 (1H, brs), 8.15 (1H, d, J = 
2.1 Hz), 7.91 (1H, dd, J = 8.8 Hz), 7.85 (1H, dd, J = 2.1 Hz, 8.8 Hz); 13C-NMR (75 MHz, DMSO-
d6) δ: 176.3, 163.5, 139.5, 139.0, 135.3, 127.1, 126.8, 122.3, 116.8, 110.2. Anal.Calcd for 
C10H6BrNO3: C, 44.81; H, 2.26; N, 5.23. Found: C, 44.66; H, 2.23; N, 5.26. 
 
4.7.13. 3-Pyridin-4-yl-8,9,10,10a-tetrahydro-7a,10b-diazapentaleno[1,2-a]naphthalene-5,7-
dione (21c). To a degassed 3.5:1 mixture of dimethoxyethane and water (0.62 mL), compound 21b 
(50 mg, 0.16 mmol), the appropriate boronic acid (38.15 2 mg, 0.31 mmol), PdCl2(dppf) CH2Cl2 
(5.73 mg 0.0078 mmol) and NaHCO3 (39.50 mg, 0.47 mmol) were added under nitrogen. The 
mixture was heated at reflux for 9 h. Water was added (5 mL) and after extraction with EtOAc (2 × 
10 mL), the collected organic layers were dried and the solvent evaporated. Purification by flash 
chromatography (CH2Cl2/MeOH 90:10) gave the desired compound. Yellow solid (24 mg, 47%); 
mp = 240 °C; Rf : 0.44. (DCM/MeOH 90:10); 1H-NMR (300 MHz, DMSO-d6) δ: 8.68 (2H, m), 
8.55 (1H, s), 8.27 (1H, d, J = 9.2 Hz), 7.92-7.78 (3H, m), 6.40 (1H, s), 6.12 (1H, m), 3.70 (1H, m), 
2.80 (1H, m), 2.40-2.18 (2H, m), 1.71 (1H, m); 13C-NMR (75 MHz, DMSO-d6) δ: 177.2, 163.2, 
150.4 (× 2), 145.7, 143.0, 137.4, 133.3, 131.4, 126.5, 124.1, 121.2 (× 2), 117.4, 103.3, 77.6, 41.7, 
29.4, 25.6. Anal.Calcd for C19H15N3O2: C, 71.91; H, 4.76; N, 13.24. Found: C, 71.96; H, 4.77; N, 
13.22. 
 
4.7.14. 3-(4-Hydroxyphenyl)-8,9,10,10a-tetrahydro-7a,10b-diazapentaleno[1,2-a] naphthalene-
5,7-dione (21d). To a degassed 3.5:1 mixture of dimethoxyethane and water (0.62 mL), compound 
21b (50 mg, 0.16 mmol), 4-hydroxyphenylboronic acid (43 mg, 0.31 mmol), PdCl2(dppf) CH2Cl2 
(5.7 mg, 0.0078 mmol) and NaHCO3 (40 mg, 0.47 mmol) were added under nitrogen. The mixture 
was heated at reflux for 2 h. Water was added (5 mL) and after extraction with EtOAc (2 × 10 mL), 
the collected organic layers were dried and the solvent evaporated. Purification by flash 
chromatography (CH2Cl2/MeOH 19:1) gave the desired compound. Yellow sticky solid (25 mg, 
49%); Rf : 0.62 (CH2Cl2/MeOH 18:2); 1H-NMR (300 MHz, DMSO-d6) δ: 9.66 (1H, s), 8.33 (1H, d, 
J = 1.8 Hz), 8.07 (1H, dd, J = 1.8, 8.5 Hz), 7.76 (1H, d, J = 8.5 Hz), 7.65-7.55 (2H, m), 6.94-6.83 
(2H, m), 6.34 (1H, s), 6.10 15-6.05 (1H, m), 3.78-3.65 60 (1H, m), 3.54-3.42 40 (1H, m), 2.78 85-
2.70 (1H, m), 2.38-2.21 (2H, m), 1.69 (1H, m); 13C-NMR (150 MHz, DMSO-d6) δ: 174.6, 165.4, 
159.4, 144.4, 138.5, 137.5, 132.9, 131.4, 129.8, 128.5, 124.1, 118.8, 117.9, 104.5, 79.4, 43.5, 30.9, 
24.3. Anal.Calcd for C20H16N2O3: C, 72.28; H, 4.85; N, 8.43. Found: C, 72.28; H, 4.85; N, 8.43. 
Found: C, 72.55; H, 4.87; N, 8.40. 
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